NCT02813369 - Naloxegol Health Outcome Post Authorisation Safety Study | Biotech Hunter

Enrollment

10,000

Participants

Timeline

Start Date

September 30, 2016

Primary Completion Date

November 30, 2021

Study Completion Date

November 30, 2021

Conditions

Opioid Induced Constipation

Interventions

DRUG

naloxegol

non-interventional study where patients are exposed to naloxegol during normal clinical practice

DRUG

non-PAMORA laxative

non-interventional study where patients are exposed to non-peripherally acting mu-opioid receptor antagonist (PAMORA) laxative

Trial Locations (2)

Research Site, Utrecht

Research Site, Sutton